Literature DB >> 34506020

Neoadjuvant Therapy for cT2N0M0 Rectal Cancer?

Gustavo A Rubio1, Roger D Hurst1, Konstantin Umanskiy1, Benjamin D Shogan1, Neil Hyman1, Kinga Skowron Olortegui2.   

Abstract

Entities:  

Keywords:  Clinical staging; Early-stage rectal cancer; Neoadjuvant chemoradiation; Total neoadjuvant therapy; cT2N0M0

Mesh：

Year:  2021        PMID： 34506020     DOI： 10.1007/s11605-021-05125-8

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN： 1091-255X            Impact factor:   3.452


× No keyword cloud information.
  5 in total

1.  Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.

Authors:  Rolf Sauer; Torsten Liersch; Susanne Merkel; Rainer Fietkau; Werner Hohenberger; Clemens Hess; Heinz Becker; Hans-Rudolf Raab; Marie-Therese Villanueva; Helmut Witzigmann; Christian Wittekind; Tim Beissbarth; Claus Rödel
Journal:  J Clin Oncol       Date:  2012-04-23       Impact factor: 44.544

Review 2.  Outcome and Salvage Surgery Following "Watch and Wait" for Rectal Cancer after Neoadjuvant Therapy: A Systematic Review.

Authors:  Joseph C Kong; Glen R Guerra; Satish K Warrier; Robert G Ramsay; Alexander G Heriot
Journal:  Dis Colon Rectum       Date:  2017-03       Impact factor: 4.585

3.  Indistinguishable T2/T3-N0 rectal cancer on rectal magnetic resonance imaging: comparison of surgery-first and neoadjuvant chemoradiation therapy-first strategies.

Authors:  Jun Gon Kim; Kyoung Doo Song; Dong Ik Cha; Hee Cheol Kim; Jeong Il Yu
Journal:  Int J Colorectal Dis       Date:  2018-07-13       Impact factor: 2.571

4.  Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy.

Authors:  J Joshua Smith; Paul Strombom; Oliver S Chow; Campbell S Roxburgh; Patricio Lynn; Anne Eaton; Maria Widmar; Karuna Ganesh; Rona Yaeger; Andrea Cercek; Martin R Weiser; Garrett M Nash; Jose G Guillem; Larissa K F Temple; Sree B Chalasani; James L Fuqua; Iva Petkovska; Abraham J Wu; Marsha Reyngold; Efsevia Vakiani; Jinru Shia; Neil H Segal; James D Smith; Christopher Crane; Marc J Gollub; Mithat Gonen; Leonard B Saltz; Julio Garcia-Aguilar; Philip B Paty
Journal:  JAMA Oncol       Date:  2019-04-11       Impact factor: 31.777
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.